MedicaidCoverageMedium impact
Newsletter Vol. 11, No. 74
New Jersey Medicaid·NJ·Pharmacy
We identified it
Jun 20, 2026
Summary
New Jersey has updated their Medicaid and NJ FamilyCare Drug Rebate Programs by adding and removing pharmaceutical manufacturers from the approved labeler code list (Appendix F). This affects which drug manufacturers are eligible for rebate programs and may impact prescription coverage and billing for Medicaid patients.
Action Required
Review the updated Appendix F manufacturer labeler code list to identify which pharmaceutical companies have been added or removed from the NJ Medicaid drug rebate program. Verify that prescribed medications from these manufacturers are still covered under current formularies and update any internal drug coverage references accordingly.